Is reduction of viral fitness a valid antiviral approach?

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Viral fitness, the replicative adaptation of a virus to its environment, has viral and environmental determinants. Presently, growth competition assays of recombinant viruses can supply a precise evaluation of this parameter of potential clinical interest. On the basis of the data obtained by monitoring viral infections under treatment with antiviral compounds and by sequence-function analysis of drug-resistant variants, it has recently been proposed that intentional selection of viral mutants with reduced fitness could be an efficient antiviral strategy in several important viral infections of humans. From this point of view, specific antiviral compounds as well as human monoclonal antibodies targeting crucial viral proteins could be effective in modifying the viral replication capacity and the pathogenic potential of rapidly evolving RNA viruses that are normally able to escape under the pressure of treatments with single or multiple antiviral drugs.

Original languageEnglish
Pages (from-to)267-272
Number of pages6
JournalDrug Discovery Today: Therapeutic Strategies
Volume4
Issue number4
DOIs
Publication statusPublished - Dec 2007

Fingerprint

Antiviral Agents
Virus Diseases
Viruses
RNA Viruses
Viral Proteins
Sequence Analysis
Monoclonal Antibodies
Pressure
Growth
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Drug Discovery
  • Molecular Medicine

Cite this

Is reduction of viral fitness a valid antiviral approach? / Clementi, Massimo; Burioni, Roberto.

In: Drug Discovery Today: Therapeutic Strategies, Vol. 4, No. 4, 12.2007, p. 267-272.

Research output: Contribution to journalArticle

@article{29cccf36194d4989873ce5c107424a1a,
title = "Is reduction of viral fitness a valid antiviral approach?",
abstract = "Viral fitness, the replicative adaptation of a virus to its environment, has viral and environmental determinants. Presently, growth competition assays of recombinant viruses can supply a precise evaluation of this parameter of potential clinical interest. On the basis of the data obtained by monitoring viral infections under treatment with antiviral compounds and by sequence-function analysis of drug-resistant variants, it has recently been proposed that intentional selection of viral mutants with reduced fitness could be an efficient antiviral strategy in several important viral infections of humans. From this point of view, specific antiviral compounds as well as human monoclonal antibodies targeting crucial viral proteins could be effective in modifying the viral replication capacity and the pathogenic potential of rapidly evolving RNA viruses that are normally able to escape under the pressure of treatments with single or multiple antiviral drugs.",
author = "Massimo Clementi and Roberto Burioni",
year = "2007",
month = "12",
doi = "10.1016/j.ddstr.2007.12.001",
language = "English",
volume = "4",
pages = "267--272",
journal = "Drug Discovery Today: Therapeutic Strategies",
issn = "1740-6773",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Is reduction of viral fitness a valid antiviral approach?

AU - Clementi, Massimo

AU - Burioni, Roberto

PY - 2007/12

Y1 - 2007/12

N2 - Viral fitness, the replicative adaptation of a virus to its environment, has viral and environmental determinants. Presently, growth competition assays of recombinant viruses can supply a precise evaluation of this parameter of potential clinical interest. On the basis of the data obtained by monitoring viral infections under treatment with antiviral compounds and by sequence-function analysis of drug-resistant variants, it has recently been proposed that intentional selection of viral mutants with reduced fitness could be an efficient antiviral strategy in several important viral infections of humans. From this point of view, specific antiviral compounds as well as human monoclonal antibodies targeting crucial viral proteins could be effective in modifying the viral replication capacity and the pathogenic potential of rapidly evolving RNA viruses that are normally able to escape under the pressure of treatments with single or multiple antiviral drugs.

AB - Viral fitness, the replicative adaptation of a virus to its environment, has viral and environmental determinants. Presently, growth competition assays of recombinant viruses can supply a precise evaluation of this parameter of potential clinical interest. On the basis of the data obtained by monitoring viral infections under treatment with antiviral compounds and by sequence-function analysis of drug-resistant variants, it has recently been proposed that intentional selection of viral mutants with reduced fitness could be an efficient antiviral strategy in several important viral infections of humans. From this point of view, specific antiviral compounds as well as human monoclonal antibodies targeting crucial viral proteins could be effective in modifying the viral replication capacity and the pathogenic potential of rapidly evolving RNA viruses that are normally able to escape under the pressure of treatments with single or multiple antiviral drugs.

UR - http://www.scopus.com/inward/record.url?scp=46749103726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=46749103726&partnerID=8YFLogxK

U2 - 10.1016/j.ddstr.2007.12.001

DO - 10.1016/j.ddstr.2007.12.001

M3 - Article

VL - 4

SP - 267

EP - 272

JO - Drug Discovery Today: Therapeutic Strategies

JF - Drug Discovery Today: Therapeutic Strategies

SN - 1740-6773

IS - 4

ER -